Lexeo’s IPO raises $100M

The latest stories trending on MedCity News.

Editor's Pick

Top Story Lexeo's IPO Raises $100M for Gene Therapies That Treat the Heart, Protect the Brain The gene therapy programs of Lexeo Therapeutics span rare forms of cardiomyopathy and certain types of Alzheimer's disease. But Lexeo's IPO comes as a rival gene therapy developer sues the biotech, claiming its work employs stolen trade secrets. Sponsored Content Navigating Healthcare's Data Revolution: Priorities, Opportunities, and Challenges for Health Systems Presented by Arcadia Arcadia recently partnered with HIMSS Market Insights to survey executives, IT, technology, and clinical leaders. Here's what we found. Do You Want To Improve Your Patient Flow? Presented by Care Logistics Learn how you can improve your patient flow and drive operational efficiency. Plus, gain an increase in revenue per case and hard dollar benefit along with a decrease in length of stay.  Join us Nov 9th as experts discuss how hospitals can improve these and so much more during this live webinar. Reserve My Seat

Featured News

Unlocking the Power of Healthcare Audiences: Segmenting Stakeholders and Maximizing Impact This article delves into the importance of audience segmentation, offers guidance on identifying distinct audience groups, and discusses influential personas in healthcare. Revamping HHS' Complex Organizational Structure Could Improve Its Performance During Public Health Emergencies Changes in HHS structure, along with well-funded and staffed partners at the state, local, tribal and territorial levels, may prove helpful for success during future public health emergencies and can help earn and maintain the public's trust. How KelaHealth Slashed the Rate of Post-Surgical Complications at Duke A new Duke study shows that KelaHealth's platform was associated with a 21% reduction in acute kidney injury and a 24% decrease in costly readmissions following colorectal surgery. The platform delivers insights about individual patients' surgical risks and what their care journeys should look like. Report: More Than 10M People Have Been Disenrolled From Medicaid Amid the unwinding of the continuous enrollment provision, more than 10 million people have lost Medicaid coverage, according to data from KFF. Of those disenrolled from Medicaid coverage, 71% were removed from coverage for procedural reasons.

Resources

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Jeff Smith, CEO of Bamboo Health For October's guest interview, we are joined by Jeff Smith, who became the CEO of digital health company Bamboo Health this month. Before Bamboo, Smith held several leadership positions at Lumeris, a value-based care managed services operator for health systems. Before that, he spent more than six years in leadership roles at CVS. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe